<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.eurjchem.com/lib/pkp/xml/oai2.xsl" ?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/
		http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
	<responseDate>2026-05-06T11:28:10Z</responseDate>
	<request identifier="oai:ojs.www.eurjchem.com:article/2491" metadataPrefix="oai_dc" verb="GetRecord">https://www.eurjchem.com/index.php/eurjchem/oai</request>
	<GetRecord>
		<record>
			<header>
				<identifier>oai:ojs.www.eurjchem.com:article/2491</identifier>
				<datestamp>2024-03-31T05:45:09Z</datestamp>
				<setSpec>eurjchem:ART</setSpec>
				<setSpec>driver</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Synthesis, crystal structure, and spectroscopic characterization of a new non-centrosymmetric compound, 1-(2-chloroquinolin-3-yl)-N-(4-fluorobenzyl)methanimine</dc:title>
	<dc:creator>Hachicha, Maha</dc:creator>
	<dc:creator>Nasri, Rawia</dc:creator>
	<dc:creator>Zid, Mohamed Faouzi</dc:creator>
	<dc:creator>Mrabet, Hedi</dc:creator>
	<dc:subject xml:lang="en-US">Synthesis</dc:subject>
	<dc:subject xml:lang="en-US">Quinolines</dc:subject>
	<dc:subject xml:lang="en-US">X-ray diffraction</dc:subject>
	<dc:subject xml:lang="en-US">Crystal structure</dc:subject>
	<dc:subject xml:lang="en-US">NMR spectroscopy</dc:subject>
	<dc:subject xml:lang="en-US">Non-centrosymmetric</dc:subject>
	<dc:description xml:lang="en-US">In this work, we report the synthesis and characterization of a new condensed aromatic heterocycle (1-(2-chloroquinolin-3-yl)-N-(4-fluorobenzyl)methanimine) useful in various fields, mainly in medicinal and therapeutic chemistry, with interesting biological properties. Characterization of the title compound was carried out by 1H, 13C, 19F nuclear magnetic resonance and X-ray diffraction techniques. The crystal structure reveals that title compound crystallizes in the monoclinic system and crystal data for C17H12ClFN2: monoclinic, space group P21 (no. 4), a = 7.2253(10) Å, b = 5.7720(10) Å, c = 17.105(2) Å, β = 95.338(10)°, V = 710.26(18) Å3, Z = 2, T = 298(2) K, μ(MoKα) = 0.274 mm-1, Dcalc = 1.397 g/cm3, 5010 reflections measured (4.784° ≤ 2Θ ≤ 54.324°), 3160 unique (Rint = 0.0501, Rsigma = 0.0506) which were used in all calculations. The final R1 was 0.0339 (I &amp;gt; 2σ(I)) and wR2 was 0.0907 (all data). The obtained molecular structure has an antiparallel arrangement of the molecular unit leading to a one-dimensional framework.</dc:description>
	<dc:publisher xml:lang="en-US">Atlanta Publishing House LLC</dc:publisher>
	<dc:date>2024-03-31</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:format>text/plain</dc:format>
	<dc:identifier>https://www.eurjchem.com/index.php/eurjchem/article/view/2491</dc:identifier>
	<dc:identifier>10.5155/eurjchem.15.1.25-30.2491</dc:identifier>
	<dc:source xml:lang="en-US">European Journal of Chemistry; Vol. 15 No. 1 (2024): March 2024; 25-30</dc:source>
	<dc:source>2153-2257</dc:source>
	<dc:source>2153-2249</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://www.eurjchem.com/index.php/eurjchem/article/view/2491/2768</dc:relation>
	<dc:relation>https://www.eurjchem.com/index.php/eurjchem/article/view/2491/2774</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2024 Maha Hachicha, Rawia Nasri, Mohamed Faouzi Zid, Hedi Mrabet</dc:rights>
	<dc:rights xml:lang="en-US">https://creativecommons.org/licenses/by-nc/4.0</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
	</GetRecord>
</OAI-PMH>
